Italia markets closed
  • Where Will Vaxart Be in 1 Year?
    Motley Fool

    Where Will Vaxart Be in 1 Year?

    Vaxart (NASDAQ: VXRT) has a plan to address the challenge, but a recent phase 1 readout crushed the stock. When Vaxart released the preliminary data from its phase 1 trial for VXA-CoV2-1, the company's oral COVID-19 tablet vaccine candidate, the headline of the press release touted positive results. Management went so far as to express increased confidence in the drug and in the tablet vaccine platform overall.

  • 3 Moves to Ensure You're a Retirement Multimillionaire
    Motley Fool

    3 Moves to Ensure You're a Retirement Multimillionaire

    The amount of money you end up needing in retirement will depend on your personal lifestyle choices and what you want to do with your time. A few smart moves on your part could set you on a path to retiring as a multimillionaire. Rather, you'll need to reserve some of your income for your 401(k), IRA, or another retirement account in which you'll be saving.

  • Motley Fool

    2 Green Flags for Pfizer in 2021 and 1 Yellow Flag

    Pfizer (NYSE: PFE) recently reported earnings and spoke of what to expect in 2021. In this Motley Fool Live video recorded on Feb. 26, 2021, healthcare and cannabis bureau chief Corinne Cardina and contributor Adria Cimino discuss two reasons to be optimistic about Pfizer (NYSE: PFE) this year -- and one point that warrants caution. Corinne Cardina: We're going to talk a little bit about earnings.